Augmentation strategies to increase antidepressant efficacy.

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Major depressive disorder (MDD) often requires augmentation strategies when initial antidepressant monotherapies are ineffective or not tolerated.
• Treatment algorithms guide clinicians in selecting appropriate augmentation options for MDD patients.
• Current augmentation focuses on combining antidepressants, but atypical antipsychotics are increasingly utilized.

Purpose of the Study:

• To review current and emerging augmentation strategies for major depressive disorder (MDD) treatment.
• To provide clinicians with an overview of options when antidepressant monotherapy fails.
• To highlight the role of atypical antipsychotics and other novel treatments in augmenting antidepressant therapy.

Main Methods:

• Literature review of augmentation strategies for major depressive disorder (MDD).
• Analysis of current clinical practices and emerging pharmacologic and nonpharmacologic treatments.
• Synthesis of evidence on the efficacy of combining antidepressants with other agents.

Main Results:

• Atypical antipsychotics are a common and effective augmentation strategy for major depressive disorder (MDD).
• Sequenced treatment steps, guided by algorithms, improve the utilization of augmentation therapies.
• Emerging pharmacologic and nonpharmacologic interventions offer alternative augmentation options.

Conclusions:

• Augmentation strategies are crucial for achieving remission in patients with major depressive disorder (MDD) unresponsive to monotherapy.
• Atypical antipsychotics represent a significant advancement in augmenting antidepressant treatment for MDD.
• Further research into novel pharmacologic and nonpharmacologic methods is needed to expand augmentation options for MDD.